Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysis

References

• Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–717. discussion 717.
   PubMed Web of Science ®Google Scholar
• Musio D, De Felice F, Magnante AL, et al. Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma. BioMed Res Int. 2013;2013:740195.
   PubMed Web of Science ®Google Scholar
• Musio D, De Felice F, Bulzonetti N, et al. Neoadjuvant-intensified treatment for rectal cancer: time to change? World J Gastroenterol. 2013;19(20):3052–3061.
   PubMed Web of Science ®Google Scholar
• Zhang X, Ding R, Li J, et al. Efficacy and safety of the “watch-and-wait” approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis. Surg Endosc. 2022;36(4):2233–2244.
   PubMed Web of Science ®Google Scholar
• Yu G, Lu W, Jiao Z, et al. A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy. World J Surg Oncol. 2021;19(1):305.
   PubMed Web of Science ®Google Scholar
• Dossa F, Chesney TR, Acuna SA, et al. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(7):501–513.
   PubMed Web of Science ®Google Scholar
• Lezoche E, Baldarelli M, Lezoche G, et al. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg. 2012;99(9):1211–1218.
   PubMed Web of Science ®Google Scholar
• Chinese Watch & Wait Database Research Cooperation Group(CWWD), Chinese Association of Surgeons, Chinese Society of Coloproctology, Chinese Medical Doctor Association, Chinese Society of Colorectal Surgery, Chinese Medical Association, et al. Consensus on the Watch and Wait policy in rectal cancer patients after neoadjuvant treatment (2020 version). Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23(1):1–9.
   Google Scholar
• Cercek A, Roxburgh CSD, Strombom P, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4(6):e180071.
   PubMed Web of Science ®Google Scholar
• Bademler S, Koza KB, Ucuncu MZ, et al. Standardized laparoscopic sphincter-preserving total mesorectal excision for rectal cancer: median of 10 years’ long-term oncologic outcome in 217 unselected consecutive patientsSurg Laparosc. Endosc Percutan Tech. 2019;29(5):354–361
   PubMed Web of Science ®Google Scholar
• Asoglu O, Kunduz E, Serin KR, et al. Standardized laparoscopic sphincter-preserving total mesorectal excision for rectal cancer: long-term oncologic outcome in 217 unselected consecutive patients [published correction appears in Surg Laparosc Endosc Percutan Tech. 2021;31(5):662]. Surg Laparosc Endosc Percutan Tech. 2014;24(2):145–152.
   PubMed Web of Science ®Google Scholar
• Jag VDH, Qaderi SM, Verhoeven R, et al. Transanal total mesorectal excision and low anterior resection syndrome. Br J Surg. 2021;108(8):991–997.
   PubMed Web of Science ®Google Scholar
• Teste B, Rouanet P, Tuech JJ, et al. Early and late morbidity of local excision after chemoradiotherapy for rectal cancer. BJS Open. 2021;5(3):zrab043.
   PubMed Web of Science ®Google Scholar
• Lynn PB, Van der Valk M, Claassen YHM, et al. Chemoradiation and Local excision versus total mesorectal excision for T2N0 rectal cancer: comparison of short- and long-term outcomes from two prospective studies. Ann Surg. 2023;277(1):e96–e102.
   PubMed Web of Science ®Google Scholar
• Wang QX, Zhang R, Xiao WW, et al. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy. Radiat Oncol. 2021;16(1):16.
   PubMed Web of Science ®Google Scholar
• Pinto JC, Pereira AD, Pimenta A, et al. Low rectal cancer treatment strategies: a cohort study assessing watch and wait. J Cancer Res Clin Oncol. 2020;146(10):2631–2638.
   PubMed Web of Science ®Google Scholar
• Haak HE, Maas M, Lambregts DMJ, et al. Is watch and wait a safe and effective way to treat rectal cancer in older patients? Eur J Surg Oncol. 2020;46(3):358–362.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Malcomson L, Emsley R, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016;17(2):174–183.
   PubMed Web of Science ®Google Scholar
• Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019;5(4):e185896.
   PubMed Web of Science ®Google Scholar
• Martens MH, Maas M, Heijnen LA, et al. Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J Natl Cancer Inst. 2016;108(12):djw171.
   PubMedGoogle Scholar
• Lee JK, Cho JR, Song KS, et al. Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer. Ann Surg Treat Res. 2021;101(2):93–101.
   PubMed Web of Science ®Google Scholar
• Creavin B, Ryan E, Martin ST, et al. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Br J Cancer. 2017;116(2):169–174.
   PubMed Web of Science ®Google Scholar
• Vaccaro CA, Yazyi FJ, Ojra Quintana G, et al. Locally advanced rectal cancer: preliminary results of rectal preservation after neoadjuvant chemoradiotherapy. Cáncer de recto localmente avanzado: resultados preliminares de la preservación del recto después de quimiorradioterapia neoadyuvante. Cir Esp. 2016;94(5):274–279.
   PubMed Web of Science ®Google Scholar
• Al-Najami I, Jones HJ, Dickson EA, et al. Rectal cancer: watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth. Surg Oncol. 2021;37:101574.
   PubMed Web of Science ®Google Scholar
• Asoglu O, Tokmak H, Bakir B, et al. The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: the evaluation of 66 cases. Eur J Surg Oncol. 2020;46(3):402–409. [published correction appears in Eur J Surg Oncol. 2020;46(9):1774].
   PubMed Web of Science ®Google Scholar
• Yeom SS, Lee SY, Kim CH, et al. Non-operative treatment outcome for rectal cancer patient with clinical complete response after neoadjuvant chemoradiotherapy. Asian J Surg. 2019;42(8):823–831.
   PubMed Web of Science ®Google Scholar
• Wu A, Wang L, Du C, et al. Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20(4):417–424.
   PubMedGoogle Scholar
• Lee SY, Kim CH, Kim YJ, et al. Oncologic outcomes according to the treatment strategy in radiologic complete responders after neoadjuvant chemoradiation for rectal cancer. Oncology. 2015;89(6):311–318.
   PubMed Web of Science ®Google Scholar
• Zhao GH, Deng L, Ye DM, et al. Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis. World J Surg Oncol. 2020;18(1):232.
   PubMed Web of Science ®Google Scholar
• Hammarström K, Imam I, Mezheyeuski A, et al. A comprehensive evaluation of associations between routinely collected staging information and the response to (chemo)radiotherapy in rectal cancer. Cancers (Basel). 2020;13(1):16.
   PubMed Web of Science ®Google Scholar
• Chadi SA, Malcomson L, Ensor J, et al. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2018;3(12):825–836.
   PubMed Web of Science ®Google Scholar
• Jankowski M, Pietrzak L, Rupiński M, et al. Watch-and-wait strategy in rectal cancer: is there a tumour size limit? Results from two pooled prospective studies. Radiother Oncol. 2021;160:229–235.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang L, Bao H, et al. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: a prospective cohort study. PLOS Med. 2021;18(8):e1003741.
   PubMed Web of Science ®Google Scholar
• Fiorica F, Trovò M, Anania G, et al. Is it possible a conservative approach after radiochemotherapy in locally advanced rectal cancer (LARC)? A systematic review of the literature and meta-analysis. J Gastrointest Cancer. 2019;50(1):98–108.
   PubMed Web of Science ®Google Scholar
• Marchegiani F, Palatucci V, Capelli G, et al. Rectal sparing approach after neoadjuvant therapy in patients with rectal cancer: the preliminary results of the ReSARCh trial. Ann Surg Oncol. 2022;29(3):1880–1889.
   PubMed Web of Science ®Google Scholar
• Fernandez LM, Gp SJ, NL F, et al. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol. 2021;22(1):43–50.
   PubMed Web of Science ®Google Scholar
• Thomas CR Jr. Is watch-and-wait ready for prime time?: it depends on priming of the multidisciplinary care team. JAMA Oncol. 2019;5(4):e185895.
   PubMed Web of Science ®Google Scholar
• Bach SP, Gilbert A, Brock K, et al. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterol Hepatol. 2021;6(2):92–105.
   PubMed Web of Science ®Google Scholar
• Bach SP, Collaborative S-TAR-TREC. Can we Save the rectum by watchful waiting or transanal surgery following (chemo)Radiotherapy versus total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches. Colorectal Dis. 2022;24(5):639–651.
   PubMed Web of Science ®Google Scholar
• Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40(23):2546–2556.
   PubMed Web of Science ®Google Scholar
• Ding P[Immunotherapy for microsatellite⁃instability⁃high advanced colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2022;25(3):199–204.
   PubMedGoogle Scholar
• Li YJ, Zhang L, Dong QS, et al. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors]. Zhonghua Wei Chang Wai Ke Za Zhi. 2021;24(11):998–1007.
   PubMedGoogle Scholar
• Cercek A, Lumish M, Sinopoli J, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022;386(25):2363–2376.
   PubMed Web of Science ®Google Scholar
• Kaul S, Rao C, Mane R, et al. Is the management of rectal cancer using a watch and wait approach feasible, safe and effective in a publicly funded general hospital? Clin Oncol. 2022;34(1):e25–e34. (R Coll Radiol).
   Web of Science ®Google Scholar